A monthly video conference series about how you and LLS are advancing blood cancer research in the quest for cures.
With hosts Drs. Lou DeGennaro, Gwen Nichols and Lee Greenberger
An Update on The LLS Children's Initiative
Tuesday, June 29 at 1:00PM ET
Through The LLS Children’s Initiative, LLS is leveraging its role in the oncology community as a patient-centered convener to forge a groundbreaking collaboration to bring the power of precision medicine to pediatric patients. We seek no less than to transform the standard of care for children. May 2021 marks the two-year anniversary of launching this ambitious global effort. Join LLS leaders and our special guest, a leading pediatric researcher and chair of the Target & Biomarker Subcommittee of the LLS PedAL Master Clinical Trial, for an update on the progress and an outlook for what we can expect to see when the PedAL trial opens to enrollment later this year.
Soheil Meshinchi, MD, PhD (Fred Hutchinson Cancer Research Center) is a pediatric hematologist-oncologist focused on high-risk leukemias. He is a widely regarded expert in targeted therapies for patients with acute myeloid leukemia, stem cell transplantation for patients with pediatric leukemia and in the management of post-transplant relapse. He serves as the chairman of the Children’s Oncology Group (COG) Myeloid Disease Biology Committee, the director of the COG Integrated Translational Research Center, and the vice chair of the COG Myeloid Disease Committee, and chairs the Target & Biomarker Subcommittee for the LLS Children’s Initiative PedAL Master Clinical Trial. Dr. Meshinchi’s laboratory is focused on the identification and functional evaluation of molecular alterations in leukemias to advance novel biomarkers for clinical risk assessment and for use as therapeutic targets.
April 2021: LLS IMPACT: Bringing Leading-Edge Care to Underserved Communities (video here)
March 2021: Risks and Responses: COVID-19 Vaccines and Blood Cancer Patients (video here)
January 2021: Recent Advances and New Opportunities in Blood Cancer Research and Treatment (video here)
November 2020: Blood Cancer Prevention & Survivorship (video here)
October 2020: LLS's Venture Philanthropy Model for Accelerating Promising Therapies (video here)
September 2020: The Remarkable Promise of Immunotherapy (video here)
August 2020: Research at the Intersection of COVID-19 and Blood Cancer (video here)
July 2020: A Panel Discussion on the Career Development Program (video here)